Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2023
New Titles 2022
Price and Ordering Information
Subscription Rates 2022
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Advertising Policy
Journals and eBooks Catalog
Media-Pack-2022
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
Fabricating and Stating False Information
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Short Guide
Journal Catalog 2021
Journal Catalog 2022
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Research Misconduct
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Medicinal Chemistry
Volume 29, 42 Issues, 2022
ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)
This journal supports open access
Impact Factor:
4.53
5 Year Impact Factor:
4.676
Subscribe to this Journal
Call for Editors
Book Proposal
Become an Executive Guest Editor
New Journal Proposal
Become a Section Editor
Submit Abstract Online
Become a Reviewer
Join Editorial Board
Thematic Issue Proposal
Contents
Current Medicinal Chemistry
,
Volume 11
- Number 24
Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2
,
11
(
24
):
3147
- 3161
W. Kiefer and G. Dannhardt
DOI:
10.2174/0929867043363668
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
,
11
(
24
):
3163
- 3184
Faustino Mollinedo, Consuelo Gajate, Sonsoles Martin-Santamaria and Federico Gago
DOI:
10.2174/0929867043363703
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Current Perspectives on the Therapeutic Utility of VR1 Antagonists
,
11
(
24
):
3185
- 3202
K. J. Valenzano and Q. Sun
DOI:
10.2174/0929867043363686
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Proteomics: State of the Art and its Application in Cardiovascular Research
,
11
(
24
):
3203
- 3218
Sergiu Scobioala, Rainer Klocke, Gunter Michel, Michael Kuhlmann and Sigrid Nikol
DOI:
10.2174/0929867043363767
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Effect of the Antifibrillatory Compound Tedisamil (KC-8857) on Transmembrane Currents in Mammalian Ventricular Myocytes
,
11
(
24
):
3219
- 3228
N. Jost, L. Virag, O. Hala, A. Varro, D. Thormahlen and J. Gy. Papp
DOI:
10.2174/0929867043363631
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Sequence Variants of the Ligand-Binding Domain of the Glucocorticoid Receptor Gene and their Functional Consequences on the Three- Dimensional Protein Structure
,
11
(
24
):
3229
- 3237
Istvan Liko, Peter Igaz, Attila Patocs, Szilvia Toth, Tamas Pazmany, Miklos Toth and Karoly Racz
DOI:
10.2174/0929867043363749
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Furocoumarins in Medicinal Chemistry. Synthesis, Natural Occurrence and Biological Activity
,
11
(
24
):
3239
- 3261
L. Santana, E. Uriarte, F. Roleira, N. Milhazes and F. Borges
DOI:
10.2174/0929867043363721
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Recent Advances in Design, Synthesis and Biological Activity of Aminoalkylsulfonates and Sulfonamidopeptides
,
11
(
24
):
3263
- 3278
Ales Obreza and Stanislav Gobec
DOI:
10.2174/0929867043363659
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Atta-ur-Rahman
, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
View Full Editorial Board
Nobel Laureates on Editorial Board
Prof.
John Gurdon
(UK)
Prof.
Jean-Marie Lehn
(France)
Prof.
Ferid Murad
(USA)
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Fabricating and Stating False Information
⇨ Research Misconduct
⇨ Post Publication Discussions and Corrections
⇨ Allegations from Whistleblowers
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Graphical Abstracts
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2021
⇨ Journal Catalog 2022
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Medicinal Chemistry was introduced in 1994 with the assistance of Dr. Atta-ur-Rahman, who is the current Editor-in-Chief serving since 1994.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2022 Bentham Science
|
Privacy Policy